Pulmonary fibrosis

Pulmonary fibrosis is a progressive and chronic lung disease in cats characterized by the gradual replacement of normal, healthy lung tissue with thick, stiff scar tissue. This scarring process interferes with the lungs' ability to expand properly and exchange oxygen and carbon dioxide, leading to progressive respiratory difficulty. The condition represents one of the more challenging respiratory diseases in feline medicine because it is irreversible and tends to worsen over time despite treatment. Pulmonary fibrosis is most commonly diagnosed in middle-aged to senior cats, though it can occasionally affect younger animals.

The development of pulmonary fibrosis involves abnormal healing and tissue remodeling within the lungs. When lung tissue is damaged, the normal repair process sometimes goes awry, resulting in excessive deposition of collagen and other fibrous materials in the lung interstitium, the supportive tissue framework of the lungs. This fibrotic tissue is stiff and non-functional, unable to participate in gas exchange. In many feline cases, the exact trigger for this abnormal fibrotic response cannot be identified, leading to a diagnosis of idiopathic pulmonary fibrosis. Known causes include chronic infections, inhaled toxins, and certain inflammatory conditions, though many cases occur without an identifiable preceding cause.

The impact of pulmonary fibrosis on affected cats is significant and progressive. As more lung tissue is replaced by scar tissue, the cat's breathing becomes increasingly labored. Exercise intolerance develops early, with affected cats becoming winded after minimal activity. Oxygen levels in the blood decline, leading to fatigue, reduced activity, and eventually respiratory distress. The condition substantially affects quality of life, particularly in its later stages. Because cats are adept at hiding illness and naturally tend to be inactive, early stages of pulmonary fibrosis may go unnoticed until the disease has progressed significantly.

While pulmonary fibrosis cannot be cured or reversed, management strategies can help slow progression and maintain quality of life for affected cats. Treatment focuses on reducing inflammation, providing respiratory support, and managing symptoms. Early detection allows for earlier intervention, which may help preserve remaining lung function for longer. Cat owners should be aware of the subtle signs of respiratory disease, particularly in older cats, and seek veterinary evaluation for any persistent breathing changes. Working closely with a veterinarian to optimize management can help affected cats maintain reasonable comfort and quality of life for months to years after diagnosis.

The causes of pulmonary fibrosis in cats are varied, and in many cases, the specific trigger cannot be identified. Idiopathic pulmonary fibrosis, where no underlying cause can be determined, is the most commonly diagnosed form in cats. In these cases, the fibrotic process appears to begin spontaneously, possibly triggered by an unidentified environmental exposure or as part of abnormal aging processes in the lungs. Chronic inflammation from any source can lead to fibrotic changes, as the sustained inflammatory response eventually results in excessive scar tissue formation during the healing process. Repeated low-grade insults to the lung tissue may accumulate over time, eventually triggering the fibrotic cascade.

Genetic and breed-related factors appear to play a role in feline pulmonary fibrosis, though the specific genetic mechanisms are not well characterized. Certain breeds, particularly West Highland White Terriers in dogs, have well-documented predispositions to pulmonary fibrosis, and similar breed associations are being investigated in cats. Anecdotal evidence suggests that certain cat breeds may be overrepresented among pulmonary fibrosis cases, though large-scale studies are limited. The condition appears to have a hereditary component in some families of cats, with multiple related individuals sometimes affected. Research into the genetic basis of idiopathic pulmonary fibrosis continues to advance our understanding of this complex disease.

Environmental and lifestyle factors contribute to the development of pulmonary fibrosis in some cats. Chronic exposure to inhaled irritants including cigarette smoke, dust, mold, and aerosol sprays may damage lung tissue and trigger fibrotic responses. Occupational or environmental exposures to certain chemicals, fibers, or dusts have been implicated in human pulmonary fibrosis, and similar exposures may affect cats. Indoor air quality plays a role, with poorly ventilated homes potentially exposing cats to higher concentrations of respiratory irritants. Outdoor cats may encounter environmental toxins, agricultural chemicals, or pollutants that affect lung health. Chronic aspiration of small amounts of food or gastric contents may also contribute to lung damage and subsequent fibrosis.

Several risk factors increase a cat's likelihood of developing pulmonary fibrosis. Advanced age is the most significant risk factor, with most cases occurring in cats over ten years of age. This age association may reflect cumulative lung damage, age-related changes in immune function and tissue repair, or longer exposure to environmental triggers. Pre-existing lung conditions, particularly chronic bronchitis or asthma, may predispose to fibrotic changes. Previous lung infections, especially if severe or repeated, can leave residual damage that progresses to fibrosis. Gastroesophageal reflux disease, which leads to chronic microaspiration, has been associated with pulmonary fibrosis in humans and may affect cats similarly.

The mechanism by which pulmonary fibrosis develops involves a complex interplay between injury, inflammation, and abnormal tissue repair. When lung tissue is damaged, specialized cells called fibroblasts are activated to produce collagen and repair the injury. In pulmonary fibrosis, this repair process becomes dysregulated. Fibroblasts proliferate excessively and produce abnormal amounts of collagen and other extracellular matrix proteins. The resulting scar tissue progressively replaces normal lung tissue, thickening the walls of the air sacs and the tissue between them. This thickening creates a barrier to oxygen diffusion, making gas exchange increasingly inefficient. Additionally, the stiffened lung tissue cannot expand normally, reducing the volume of air that can be inhaled with each breath.

Early warning signs of pulmonary fibrosis in cats are often subtle and easily attributed to normal aging or other less serious conditions. The first noticeable sign is typically exercise intolerance, where cats tire more quickly during play or become winded after climbing stairs or jumping. Some owners notice that their cat has become less active or playful without an obvious cause. Resting respiratory rate may be slightly elevated, though this change can be difficult to detect without deliberately counting breaths. Occasional coughing may occur, though coughing is less common in feline pulmonary fibrosis than in some other respiratory conditions. Because these early changes develop gradually and cats naturally reduce their activity levels with age, initial symptoms are frequently overlooked.

As pulmonary fibrosis progresses, respiratory symptoms become more apparent and concerning. Affected cats develop increased respiratory effort, with visible movement of the chest and sometimes the abdomen during breathing. Breathing rate increases as the cat compensates for reduced oxygen exchange by taking more frequent breaths. A dry, non-productive cough may develop or become more frequent if it was present earlier. Some cats develop audible breathing sounds, including crackles that can sometimes be heard without a stethoscope when in close proximity to the cat. The cat's breathing pattern may change, with shorter, more rapid breaths replacing the normal relaxed respiratory rhythm.

Behavioral changes associated with pulmonary fibrosis reflect the cat's difficulty breathing and declining energy levels. Affected cats become progressively more lethargic and may spend most of their time resting. They often seek out cool areas and may lie with their chest elevated or neck extended to facilitate breathing. Appetite typically decreases as the disease progresses, and weight loss becomes noticeable. Some cats become withdrawn and less interactive with family members. Sleep patterns may be disrupted, with cats showing restlessness at night due to breathing difficulty. Grooming often decreases, leading to a dull, unkempt coat.

Physical signs visible to owners include changes in breathing patterns, body condition, and overall appearance. Increased abdominal effort during breathing becomes evident as the disease advances, with the belly visibly moving in and out with each breath. Gum color may appear slightly pale or, in advanced cases, bluish-tinged due to poor oxygenation. Weight loss and muscle wasting give affected cats a thin, bony appearance. The coat often looks poor due to decreased grooming. Some cats develop a characteristic crouched posture with elbows abducted and neck extended forward to maximize air intake. Open-mouth breathing, while less common in chronic fibrosis compared to acute conditions, may occur during stress or exertion.

The progression of symptoms in pulmonary fibrosis is typically gradual, occurring over months to years rather than days to weeks. The rate of progression varies among individual cats, with some remaining relatively stable for extended periods while others decline more rapidly. Periods of stability may alternate with episodes of worsening, sometimes triggered by respiratory infections, stress, or environmental factors. Over time, the baseline respiratory status gradually declines as more lung tissue is replaced by scar tissue. Understanding this progressive nature helps owners and veterinarians plan for evolving care needs and reassess treatment strategies regularly.

Emergency symptoms requiring immediate veterinary attention include sudden worsening of breathing difficulty, open-mouth breathing, collapse, blue or purple discoloration of the tongue or gums, and complete inability or unwillingness to move. While pulmonary fibrosis is a chronic disease, affected cats can experience acute decompensation, particularly if they develop secondary infections or concurrent heart problems. Any significant change from the cat's normal respiratory baseline should prompt veterinary evaluation. Stress and overexertion should be avoided in cats with pulmonary fibrosis, as their limited respiratory reserve may be quickly overwhelmed.

The initial examination of a cat with suspected pulmonary fibrosis involves a thorough history and physical assessment. The veterinarian will ask detailed questions about the onset and progression of symptoms, any known exposures to respiratory irritants, previous respiratory conditions, and the cat's overall health history. Physical examination includes careful auscultation of the lungs, often revealing characteristic crackles or harsh breath sounds. The breathing pattern is observed, noting any increased rate or effort. Heart sounds are evaluated to identify any concurrent cardiac disease, which is common in older cats presenting with respiratory symptoms. The veterinarian assesses overall body condition, looking for weight loss and muscle wasting that often accompany chronic respiratory disease.

Diagnostic imaging plays a central role in diagnosing pulmonary fibrosis. Thoracic radiographs (chest X-rays) typically show characteristic changes including increased interstitial patterns, particularly in the caudal (back) lung lobes. The lung tissue often appears denser than normal, with a reticular or honeycomb pattern in advanced cases. These radiographic changes can suggest pulmonary fibrosis but are not definitive, as other conditions can produce similar patterns. High-resolution computed tomography (CT) provides more detailed imaging of the lung tissue and can reveal fibrotic changes not visible on standard radiographs. CT imaging has become increasingly important in diagnosing and characterizing the extent of pulmonary fibrosis. Echocardiography may be performed to evaluate heart function and rule out cardiac causes of respiratory symptoms.

Additional diagnostic procedures may be needed to confirm the diagnosis and rule out other conditions. Bronchoalveolar lavage, where fluid is instilled into and recovered from the airways, allows examination of cells and material from deep within the lungs. This can help differentiate fibrosis from other conditions like pneumonia or cancer. Lung biopsy provides the most definitive diagnosis but is an invasive procedure that carries risks for cats with already compromised lung function. Biopsy may be obtained surgically or through minimally invasive thoracoscopy. Blood tests including complete blood count, chemistry panel, and arterial blood gas analysis help assess overall health and the degree of oxygen compromise. Testing for specific infectious agents may be performed if an underlying infectious cause is suspected.

Differential diagnosis for pulmonary fibrosis includes several other conditions that can cause similar clinical signs and radiographic changes. Feline asthma causes respiratory difficulty but is characterized by airway inflammation rather than interstitial fibrosis. Chronic bronchitis, pneumonia, lung cancer, and pulmonary edema must all be considered and ruled out through appropriate testing. Heart disease causing secondary lung changes is an important differential, particularly in older cats. Pleural effusion can cause breathing difficulty but has distinct physical examination and imaging findings. The diagnostic process aims to confidently identify pulmonary fibrosis while ruling out treatable conditions that might otherwise be missed. Once a diagnosis is established, baseline assessments of lung function and disease extent help guide treatment planning and allow monitoring of progression.

There is no emergency treatment protocol specific to pulmonary fibrosis, as this is a chronic condition rather than an acute emergency. However, cats with pulmonary fibrosis can experience acute worsening of their condition requiring urgent care. In these situations, oxygen therapy is provided to support the cat's breathing while the cause of decompensation is investigated. Stress reduction is essential, as respiratory compromise can worsen rapidly with increased oxygen demand. If secondary bacterial infection is suspected or confirmed, appropriate antibiotics are initiated. Stabilization focuses on supporting respiratory function while addressing any treatable precipitating factors such as concurrent heart failure or infection.

Medical management of pulmonary fibrosis aims to reduce inflammation, slow disease progression, and maintain quality of life. Corticosteroids such as prednisolone are commonly prescribed to reduce inflammation within the lungs, though their efficacy in established fibrosis is limited. Some cats show clinical improvement with steroid therapy, particularly if there is an active inflammatory component to their disease. Bronchodilators may be added to help open airways and ease breathing, though their benefit varies among individual patients. Anti-fibrotic medications used in human medicine are being investigated for veterinary use but are not yet standard of care. Treatment is typically lifelong and requires regular adjustment based on clinical response.

Surgical options are extremely limited for pulmonary fibrosis. Unlike some lung conditions that can be addressed with surgical resection, the diffuse nature of fibrosis makes surgical treatment impractical. Lung transplantation, while performed in humans with end-stage pulmonary fibrosis, is not available for cats. In rare cases where a localized lung mass or abscess is identified alongside fibrosis, surgical intervention for that specific lesion may be considered. The focus of management therefore remains on medical therapy and supportive care rather than surgical approaches.

Supportive care forms the cornerstone of managing cats with pulmonary fibrosis. Oxygen supplementation at home may be recommended for cats with significant oxygen compromise, using specialized oxygen cages or flow systems. Weight management is important, as both obesity and cachexia negatively impact respiratory function. Maintaining adequate nutrition helps preserve muscle mass and overall strength. Environmental modifications to improve air quality and reduce respiratory irritants can help minimize additional lung stress. Stress reduction is emphasized, as anxiety increases respiratory demand. Humidification of the home environment may help some cats breathe more comfortably.

Complementary treatments and supportive therapies may provide additional benefit for some cats with pulmonary fibrosis. N-acetylcysteine, an antioxidant, has shown some promise in managing fibrotic lung disease and may be recommended by some veterinarians. Omega-3 fatty acid supplementation may have anti-inflammatory benefits. Traditional Chinese medicine and acupuncture are pursued by some owners as complementary approaches, though scientific evidence in feline pulmonary fibrosis is limited. Physical therapy focused on maintaining mobility and preventing muscle wasting may be beneficial. Regular monitoring and adjustment of the treatment plan ensure that therapy remains optimized as the disease evolves.

Treatment decisions are individualized based on disease severity, rate of progression, and owner capabilities and resources. The cost of ongoing medication, oxygen equipment, and regular veterinary monitoring can be substantial. Veterinarians work with owners to develop practical treatment plans that balance medical management with quality of life considerations. Expected outcomes are discussed honestly, with acknowledgment that pulmonary fibrosis is not curable but can often be managed for extended periods. The goal of treatment shifts toward maintaining comfort and quality of life rather than achieving cure, with regular reassessment of whether the cat continues to experience an acceptable quality of life.

Unlike many diseases where recovery implies return to normal health, pulmonary fibrosis is a progressive condition without true recovery. Instead, management focuses on stabilizing the disease, slowing progression, and maintaining quality of life for as long as possible. Following diagnosis and initiation of treatment, cats may show improvement in clinical signs over several weeks as inflammation is reduced and medications take effect. This initial response provides a new baseline from which ongoing status is assessed. Some cats achieve stable disease that progresses slowly over months to years, while others experience continued decline despite treatment. Understanding that the goal is maintenance rather than cure helps set appropriate expectations.

Ongoing care requirements for cats with pulmonary fibrosis include daily medication administration, environmental management, and regular monitoring. Most cats require lifelong medication, typically given once or twice daily. Owners learn to assess their cat's respiratory status daily, noting any changes in breathing rate, effort, or behavior. Activity is generally self-limited, with affected cats regulating their own exercise based on respiratory capacity. Stress should be minimized, as increased respiratory demand can overwhelm limited reserve. Environmental air quality should be optimized by eliminating smoke, strong fragrances, and excessive dust. Follow-up veterinary appointments every few months allow assessment of disease status and medication adjustment.

Prognostic factors in pulmonary fibrosis include the extent of disease at diagnosis, response to initial treatment, and rate of progression. Cats diagnosed earlier in the disease course, with less extensive fibrosis, generally have longer survival times. Those who respond well to anti-inflammatory medications may achieve extended periods of stability. The presence of concurrent diseases, particularly heart disease or cancer, worsens prognosis. Cats that maintain good appetite, body condition, and quality of life indicators tend to do better than those with significant weight loss and inactivity. Owner commitment to ongoing management and regular veterinary care positively influences outcomes.

The long-term outlook for cats with pulmonary fibrosis is guarded but variable. Median survival times from diagnosis range from several months to over a year in published studies, though individual cats may survive significantly longer or shorter periods. Quality of life can often be maintained at acceptable levels for extended periods with appropriate management. As the disease progresses, respiratory function gradually declines, and cats become increasingly limited in their activity. Eventually, a point is reached where quality of life deteriorates significantly, and discussions about humane euthanasia become appropriate. Throughout the disease course, the focus remains on comfort, dignity, and quality rather than quantity of life. Regular communication with the veterinary team helps owners navigate the challenges of managing this progressive disease.

Primary prevention of pulmonary fibrosis is challenging because the cause is often unknown. However, minimizing exposure to factors that may contribute to lung damage is prudent for all cats. Avoiding cigarette smoke exposure is one of the most important preventive measures, as secondhand smoke has been associated with respiratory disease in cats and may contribute to fibrotic changes. Reducing exposure to household chemicals, aerosol sprays, and strong fragrances protects lung tissue from irritant damage. Ensuring good ventilation in the home helps minimize accumulation of airborne particles and pollutants. Prompt treatment of respiratory infections may help prevent chronic damage that could lead to fibrosis.

Environmental prevention strategies focus on optimizing air quality and reducing respiratory irritants in the cat's living space. Using air purifiers with HEPA filtration can reduce airborne particles that might damage lung tissue. Choosing fragrance-free cleaning products and avoiding aerosol sprays near cats reduces chemical exposure. Dust-free or low-dust cat litters minimize inhaled particles during litter box use. Keeping cats indoors protects them from outdoor pollutants, agricultural chemicals, and other environmental toxins. Regular cleaning to reduce dust and allergen accumulation in the home benefits respiratory health. Mold should be promptly addressed, as mold spore inhalation may contribute to lung disease.

Dietary approaches to prevention focus on overall health maintenance and reducing inflammation. High-quality nutrition appropriate to the cat's life stage supports immune function and tissue health. Omega-3 fatty acid supplementation may have anti-inflammatory properties that could benefit lung health. Maintaining a healthy body weight reduces strain on the respiratory system and supports overall health. Adequate hydration helps maintain healthy respiratory secretions. While no specific diet has been proven to prevent pulmonary fibrosis, general nutritional health supports the body's ability to resist and repair tissue damage.

Regular health maintenance and veterinary care allow early detection of respiratory changes before significant fibrosis develops. Annual or biannual wellness examinations should include careful auscultation of the lungs. Owners should report any persistent cough, breathing changes, or exercise intolerance to their veterinarian promptly. Cats with chronic respiratory conditions like asthma should receive consistent management to minimize ongoing lung inflammation. Appropriate vaccination protects against respiratory infections that could cause lung damage. Senior cats, who are at highest risk for pulmonary fibrosis, benefit from more frequent health monitoring.

Early intervention when respiratory symptoms appear offers the best chance of limiting disease progression. Any persistent cough, increased breathing rate, or reduced exercise tolerance warrants veterinary evaluation. If early fibrotic changes are detected, prompt initiation of anti-inflammatory therapy may help slow progression. Baseline chest radiographs in senior cats provide reference images for comparison if respiratory changes develop later. Owners of predisposed breeds should be particularly vigilant for respiratory symptoms. While pulmonary fibrosis cannot be prevented with certainty, minimizing risk factors and ensuring early detection optimize outcomes for affected cats.

Daily management of a cat with pulmonary fibrosis requires consistent attention to medication, monitoring, and environmental factors. Most affected cats receive daily medications including anti-inflammatory drugs and possibly bronchodilators, which must be given consistently at the same times each day. Owners should develop a routine that incorporates medication administration seamlessly into daily activities. Monitoring respiratory rate and effort becomes part of daily observation, with owners learning to recognize their individual cat's normal baseline and detecting subtle changes that might indicate worsening. Keeping a log of respiratory rates, appetite, activity levels, and any symptoms helps track disease status over time and provides valuable information for veterinary visits.

Home environment modifications significantly impact comfort and quality of life for cats with pulmonary fibrosis. Air quality should be optimized by eliminating sources of smoke, strong odors, and excessive dust. Air purifiers can help reduce airborne irritants. Temperature should be kept comfortable, as extremes can stress the respiratory system. Humidity levels in the moderate range may help ease breathing for some cats. Soft, comfortable bedding in easily accessible locations reduces the need for jumping or climbing that might cause respiratory distress. Litter boxes should be kept very clean and use low-dust litter to minimize inhaled particles. Multiple resting spots at different levels allow the cat to choose the most comfortable position.

Maintaining quality of life for cats with chronic respiratory disease involves balancing medical management with emotional wellbeing and enjoyment. Affected cats should be encouraged to engage in gentle activities they enjoy, with activity level self-regulated based on respiratory capacity. Interactive play can continue at a modified pace, providing mental stimulation without respiratory stress. Favorite spots, toys, and routines should be maintained as much as possible. Affection and companionship remain important, though handling should be gentle and brief if it causes stress. Some cats may benefit from warming pads or heated beds that help them feel comfortable. Palatable, high-quality food supports nutrition and provides enjoyment even when appetite is reduced.

Ongoing monitoring and regular veterinary care are essential throughout the disease course. Follow-up appointments every two to four months allow assessment of disease status through physical examination and, periodically, chest radiographs. Blood work may be checked to monitor for medication side effects or concurrent conditions. Medication doses are adjusted based on clinical response and any side effects observed. Owners should feel comfortable contacting their veterinarian between scheduled appointments if concerns arise. Clear communication about changes in breathing, appetite, activity, or behavior helps the veterinary team provide optimal care. Quality of life assessments should be performed regularly, honestly evaluating whether the cat continues to experience more good days than bad.

Caregiver support is an important but often overlooked aspect of managing a cat with progressive disease. The emotional burden of watching a beloved cat struggle with breathing can be significant, and owners should acknowledge their own needs for support. Connecting with online communities or support groups for owners of cats with chronic diseases can provide practical advice and emotional connection. Understanding that pulmonary fibrosis is progressive helps owners prepare emotionally while making the most of the time they have. Financial planning for ongoing veterinary care and medications helps reduce stress. Veterinary teams can provide guidance on assessing quality of life and discussing when hospice care or humane euthanasia might become the kindest option. Being well-informed and emotionally supported helps owners provide the best possible care for their cats throughout the disease journey.

While pulmonary fibrosis can occur in any cat, certain observations suggest potential breed predispositions, though large-scale epidemiological studies in cats are limited. Anecdotal reports and small studies have suggested that domestic shorthair cats may be commonly affected, likely reflecting their prevalence in the general cat population. Some veterinary specialists have observed possible overrepresentation of certain breeds including Persians and Himalayans, which may relate to their flat-faced conformation affecting respiratory dynamics, though direct causation is not established. Research into breed-specific risks continues to evolve as more cases are documented and genetic factors are investigated.

Beyond specific breeds, certain categories of cats face increased risk for pulmonary fibrosis. Age is the most consistent risk factor, with the vast majority of cases occurring in cats over eight years of age and peak incidence in cats between ten and fifteen years. This age association may reflect cumulative environmental exposures, age-related changes in tissue repair mechanisms, or other factors that increase with time. Mixed-breed cats are commonly diagnosed, which may simply reflect their numerical predominance in the cat population. Cats with chronic respiratory conditions, including those with long-standing asthma or recurrent bronchitis, may be at increased risk as ongoing inflammation could predispose to fibrotic changes. Cats with history of severe respiratory infections might also face elevated risk.

Screening recommendations for pulmonary fibrosis are less well-established than for conditions like heart disease. General guidelines suggest that senior cats, particularly those over ten years of age, should receive thorough respiratory assessment during routine examinations. Any cat presenting with chronic cough, exercise intolerance, or increased respiratory effort should undergo chest radiographs to evaluate for pulmonary fibrosis and other lung diseases. Cats with known risk factors, including chronic respiratory conditions or significant smoke exposure, may benefit from periodic chest imaging even in the absence of obvious symptoms. Early detection allows for earlier intervention, which may help slow progression. Owners of older cats should be educated about the signs of respiratory disease and encouraged to report any changes promptly.

Several conditions commonly co-occur with pulmonary fibrosis or share similar clinical presentations. Feline asthma and chronic bronchitis frequently occur in the same cats that develop pulmonary fibrosis, and there may be a pathophysiological connection between chronic airway inflammation and eventual fibrotic changes. Cats with long-standing asthma may develop secondary fibrosis as repeated inflammatory episodes cause cumulative lung damage. Heart disease, particularly hypertrophic cardiomyopathy, is common in older cats and can occur concurrently with pulmonary fibrosis, creating diagnostic and management challenges. Both conditions cause respiratory difficulty, and distinguishing between cardiac and pulmonary causes of symptoms is important for optimal treatment. Chronic kidney disease often affects the same age group as pulmonary fibrosis and may complicate medication choices.

Conditions with clinical presentations similar to pulmonary fibrosis include several important differential diagnoses. Feline asthma causes respiratory difficulty with coughing and labored breathing but responds differently to treatment than fibrosis. Chronic bronchitis produces similar symptoms and may precede or accompany fibrotic changes. Congestive heart failure can cause respiratory difficulty that may be confused with primary lung disease. Lung cancer, either primary or metastatic, can produce radiographic changes and clinical signs similar to pulmonary fibrosis. Pulmonary edema from any cause presents with acute respiratory distress. Pleural effusion causes breathing difficulty with distinct physical examination findings. Infectious pneumonia should be ruled out, particularly in cats with acute worsening of chronic respiratory signs. Thorough diagnostic evaluation differentiates these conditions and allows appropriate targeted treatment.

Complications that may develop in cats with pulmonary fibrosis include progressive respiratory failure, secondary infections, and right-sided heart disease. As fibrosis advances, the remaining functional lung tissue becomes insufficient to meet oxygen demands, leading to chronic hypoxemia and respiratory distress. Damaged, fibrotic lung tissue may be more susceptible to bacterial infections, and secondary pneumonia can cause acute worsening of an otherwise stable patient. Pulmonary hypertension, elevated blood pressure in the lung circulation, can develop secondary to chronic lung disease and eventually lead to right-sided heart failure (cor pulmonale). Weight loss and muscle wasting commonly occur as chronic respiratory effort increases metabolic demands while decreased activity leads to muscle atrophy. Recognition and treatment of complications helps maintain quality of life as the underlying disease progresses.